Ayoub WA, Kumar AA, Naguib HS, and Taylor HC
Moreover, patients losing 20-30% of their body weight also contributes to blood pressure lowering effects as well and going back to the earlier graph with 2 out of 3 patients not even being in the obese BMI category, suggests a large number of patients were probably able to reduce dose or stop their blood pressure medicine entirely but since they only had the data for a couple weeks we have to wait for confirmation on that
Comparative efficacy of tirzepatide vs
Due to these reasons, manufacturers are charging higher prices
If you are transitioning from another GLP-1 medication, the timeline may differ slightly
Adan, GLP-1 receptor agonist GLP1-S reduces appetite while increasing dopamine reward signaling, Neuroscience Applied, Volume 3, 2024, 103925, ISSN 2772-4085